BioAtla, Inc. (BCAB)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $333k
- Dec 2 · Plan not stated
- Form 4 sales
- 28
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 salePlan not statedNov 29, 2021 2021
Sold 399 shares at $23.89 ($10k)
Smith Scott Andrew, President
Sold 0.1% of holdings ($8.4M position)349,746 shares left0.1x usual sizeFiling
- 2 Form 4 salePlan not statedNov 29, 2021 same day
Sold 642 shares at $23.89 ($15k)
Vasquez Christian, Officer
Sold 2.3% of holdings ($666k position)27,238 shares leftFiling
- 3 Form 4 salePlan not statedNov 29, 2021 same day
Sold 4,599 shares at $23.89 ($110k)
Waldron Richard A, Chief Financial Officer
Sold 3% of holdings ($3.7M position)148,659 shares leftFiling
- 4 Form 4 salePlan not statedDec 2, 2021 +3 days
Sold 47,622 shares at $23.48 ($1.1M)
Short Jay M Phd, Chief Executive Officer
Sold 3.5% of holdings ($32.1M position)1.3M shares left0.8x usual sizeFiling
- 5 Form 4 salePlan not statedDec 2, 2021 same day
Sold 1,124 shares at $22.27 ($25k)
Sievers Eric, Chief Medical Officer
Sold 1.2% of holdings ($2.1M position)91,506 shares left2.2x usual sizeFiling
- 6 Form 4 salePlan not statedDec 2, 2021 same day
Sold 4,090 shares at $22.27 ($91k)
Smith Scott Andrew, President
Sold 1.2% of holdings ($7.8M position)345,656 shares left1.8x usual sizeFiling
- 7 Form 4 salePlan not statedDec 2, 2021 same day
Sold 1,979 shares at $23.48 ($46k)
Vasquez Christian, Officer
Sold 7.3% of holdings ($640k position)25,259 shares leftFiling
- 8 Form 4 salePlan not statedDec 2, 2021 same day
Sold 14,190 shares at $23.48 ($333k)
Waldron Richard A, Chief Financial Officer
Sold 9.5% of holdings ($3.5M position)134,469 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (28)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Dec 7, 2021 | Waldron Richard A | BCAB | Chief Financial Officer | Form 4 sale | 14,190 | $333k | 9.5% | Plan not stated | SEC |
| Dec 2, 2021 | Dec 7, 2021 | Vasquez Christian | BCAB | Officer | Form 4 sale | 1,979 | $46k | 7.3% | Plan not stated | SEC |
| Dec 2, 2021 | Dec 7, 2021 | Smith Scott Andrew | BCAB | President | Form 4 sale | 4,090 | $91k | 1.2% | Plan not stated | SEC |
| Dec 2, 2021 | Dec 7, 2021 | Sievers Eric | BCAB | Chief Medical Officer | Form 4 sale | 1,124 | $25k | 1.2% | Plan not stated | SEC |
| Dec 2, 2021 | Dec 7, 2021 | Short Jay M Phd | BCAB | Chief Executive Officer | Form 4 sale | 47,622 | $1.1M | 3.5% | Plan not stated | SEC |
| Nov 29, 2021 | Dec 6, 2021 | Waldron Richard A | BCAB | Chief Financial Officer | Form 4 sale | 4,599 | $110k | 3.0% | Plan not stated | SEC |
| Nov 29, 2021 | Dec 6, 2021 | Vasquez Christian | BCAB | Officer | Form 4 sale | 642 | $15k | 2.3% | Plan not stated | SEC |
| Nov 29, 2021 | Dec 6, 2021 | Smith Scott Andrew | BCAB | President | Form 4 sale | 399 | $10k | 0.1% | Plan not stated | SEC |
| Nov 29, 2021 | Dec 6, 2021 | Sievers Eric | BCAB | Chief Medical Officer | Form 4 sale | 110 | $3k | 0.1% | Plan not stated | SEC |
| Nov 29, 2021 | Dec 6, 2021 | Short Jay M Phd | BCAB | Chief Executive Officer | Form 4 sale | 15,435 | $369k | 1.1% | Plan not stated | SEC |
| Nov 24, 2021 | Nov 30, 2021 | Waldron Richard A | BCAB | Chief Financial Officer | Form 4 sale | 13,333 | $337k | 8.0% | Plan not stated | SEC |
| Nov 24, 2021 | Nov 30, 2021 | Vasquez Christian | BCAB | Officer | Form 4 sale | 2,541 | $64k | 8.4% | Plan not stated | SEC |
| Nov 24, 2021 | Nov 30, 2021 | Smith Scott Andrew | BCAB | President | Form 4 sale | 1,580 | $40k | 0.4% | Plan not stated | SEC |
| Nov 24, 2021 | Nov 30, 2021 | Sievers Eric | BCAB | Chief Medical Officer | Form 4 sale | 434 | $11k | 0.5% | Plan not stated | SEC |
| Nov 24, 2021 | Nov 30, 2021 | Short Jay M Phd | BCAB | Chief Executive Officer | Form 4 sale | 57,640 | $1.5M | 4.0% | Plan not stated | SEC |
| Nov 2, 2021 | Nov 3, 2021 | Steinman Lawrence | BCAB | Director | Form 4 sale | 450 | $14k | 2.4% | Plan not stated | SEC |
| Oct 1, 2021 | Oct 7, 2021 | Smith Scott Andrew | BCAB | President | Form 4 sale | 2,994 | $90k | 0.8% | Plan not stated | SEC |
| Oct 1, 2021 | Oct 7, 2021 | Sievers Eric | BCAB | Chief Medical Officer | Form 4 sale | 592 | $18k | 0.6% | Plan not stated | SEC |
| Sep 15, 2021 | Sep 17, 2021 | Steinman Lawrence | BCAB | Director | Form 4 sale | 450 | $17k | 2.3% | Plan not stated | SEC |
| Aug 26, 2021 | Aug 30, 2021 | Smith Scott Andrew | BCAB | President | Form 4 sale | 33,244 | $1.3M | 8.6% | Plan not stated | SEC |
| Aug 26, 2021 | Aug 30, 2021 | Sievers Eric | BCAB | Chief Medical Officer | Form 4 sale | 6,883 | $272k | 6.8% | Plan not stated | SEC |
| Aug 24, 2021 | Aug 26, 2021 | Short Jay M Phd | BCAB | Chief Executive Officer | Form 4 sale | 4,533 | $189k | 0.6% | Plan not stated | SEC |
| Aug 24, 2021 | Aug 26, 2021 | Levy Guy | BCAB | Director | Form 4 sale | 546,709 | $21.7M | 39.2% | Unusual | SEC |
| Aug 16, 2021 | Aug 18, 2021 | Steinman Lawrence | BCAB | Director | Form 4 sale | 450 | $18k | 2.3% | Plan not stated | SEC |
| Jul 15, 2021 | Jul 19, 2021 | Steinman Lawrence | BCAB | Director | Form 4 sale | 450 | $17k | 2.2% | Plan not stated | SEC |
| Jun 21, 2021 | Jun 22, 2021 | Short Jay M Phd | BCAB | Chief Executive Officer | Form 4 sale | 74,269 | $2.9M | 8.6% | Plan not stated | SEC |
| Jun 17, 2021 | Jun 21, 2021 | Levy Guy | BCAB | Director | Form 4 sale | 400,000 | $15.7M | 59.7% | Unusual | SEC |
| Jun 16, 2021 | Jun 16, 2021 | Short Jay M Phd | BCAB | Chief Executive Officer | Form 4 sale | 146,137 | $5.9M | 14.5% | Plan not stated | SEC |